Advisory Services Network’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
AC
NAMI
SIMG
Advisory Services Network's SUPN Position: Q2 2026 in Review
Advisory Services Network sold out of Supernus Pharmaceuticals (SUPN) in Q2 2026, closing a stake of 235 shares — an estimated $12.1K sold.
Advisory Services Network first reported a position in SUPN in Q1 2017 and held it in 18 quarters. The position peaked at $23K in Q3 2019. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Advisory Services Network reported no remaining Supernus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 235 Supernus Pharmaceuticals shares in Q2 2026, an estimated $12.1K.
- Advisory Services Network first reported a position in Supernus Pharmaceuticals in Q1 2017 and held it in 18 quarters.
- Advisory Services Network's Supernus Pharmaceuticals position peaked at $23K in Q3 2019.
- 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.